U.S. stocks pared some earlier losses toward the end trading, with the Nasdaq jumping 2% on Thursday. US President Biden, during his press briefing on Ukraine/Russia, said he has authorized additional US military deployments today after Russia’s President Vladimir Putin announced that the country’s armed forces would carry out a “special military operation” in Ukraine.
The Dow traded down 0.66% to 32,912.79 while the NASDAQ rose 2% to 13,298.18. The S&P also rose, gaining, 0.35% to 4,240.12.
Check out this: Insiders Buy More Than $170M Of 4 Stocks
Leading and Lagging Sectors
Communication services shares climbed by 0.9% on Thursday. Meanwhile, top gainers in the sector included Globalstar, Inc. GSAT, up 17% and Tremor International Ltd TRMR up 13%.
In trading on Thursday, financials shares dipped 3.4%.
Moderna, Inc. MRNA reported better-than-expected results for its fourth quarter and announces a new $3 billion buyback program.
Moderna posted quarterly earnings of $11.29 per share, beating analysts’ estimates of $9.90 per share. The company’s quarterly sales came in at $7.20 billion, versus expectations of $6.79 billion.
Moderna also raised its 2022 signed advance purchase agreements to around $19 billion, with additional signed options of about $3 billion.
Equities Trading UP
TransMedics Group, Inc. TMDX shares shot up 26% to $15.79 following strong quarterly sales.
Shares of South Jersey Industries, Inc. SJI got a boost, shooting 40% to $32.95 after the company announced it will be acquired by the Infrastructure Investments Fund. South Jersey Industries also reported upbeat quarterly earnings.
Lantheus Holdings, Inc. LNTH shares were also up, gaining 35% to $38.94 after the company reported better-than-expected Q4 EPS and sales results and issued Q1 adjusted EPS and sales guidance and FY22 sales guidance above estimates.
Equities Trading DOWN
Orphazyme A/S ORPH shares tumbled 33% to $1.3601 as the company said it has been notified by the European Medicines Agency's Committee for Medicinal Products for Human Use of a negative trend vote on marketing authorization application for its investigational product candidate, arimoclomol, for the treatment of Niemann-Pick disease type C.
Shares of Bandwidth Inc. BAND were down 33% to $31.37 after the company issued a weak Q1 forecast.
Versus Systems Inc. VS was down, falling 41% to $1.2150 as the company reported the pricing of its public offering
In commodity news, oil traded up 2.2% to $94.15, while gold traded up 0.6% to $1,921.20.
Silver traded down 0.1% Thursday to $24.535 while copper fell 0.2% to $4.4740.
European shares closed lower today. The eurozone’s STOXX 600 dropped 3.28%, London’s FTSE 100 fell 3.88%, while Spain’s IBEX 35 Index fell 2.86%. The German DAX tumbled 3.96%, French CAC 40 fell 3.83% and Italy’s FTSE MIB Index dipped 4.14%.
The consumer confidence index in France declined by 1 point to 98 in February, while the CBI distributive trades survey’s retail sales balance in the UK declined to 14 in February from 28 in the previous month.
The US economy expanded an annualized 7% on quarter during the fourth quarter, up from 6.9% in the advance estimate.
US initial jobless claims fell by 17,000 to 232,000 in the week ended February 19th.
The Chicago Fed National Activity Index in rose to +0.69 in January from a revised level of 0.07 in the prior month.
New home sales dropped 4.5% to an annual rate of 801,000 in January.
US natural-gas stocks dropped 129 billion cubic feet last week, the Energy Information Administration said.
US crude oil inventories increased 4.515 million barrels in the week ended February 18th, the EIA said.
Federal Reserve Governor Christopher Waller will speak at 8:00 p.m. ET.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 80,372,400 cases with around 966,530 deaths. India confirmed a total of at least 42,881,170 cases and 512,950 deaths, while Brazil reported over 28,485,500 COVID-19 cases with 646,490 deaths. In total, there were at least 430,661,700 cases of COVID-19 worldwide with more than 5,939,600 deaths.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.